RedHill Biopharma Ltd (RDHL) has released an update.
RedHill Biopharma Ltd.’s shareholders have approved a proposal to increase the company’s authorized share capital during the Extraordinary General Meeting held on March 21, 2024. This move is expected to have significant implications for the company’s growth strategy and financial flexibility. The decision is now incorporated into various registration statements filed with the Securities and Exchange Commission.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
